Early Detection of COVID-19: How Your Smartwatch Could Help
Duke researchers aim to detect coronavirus infections early in CovIdentify study. News of the first U.S. coronavirus case hit the American public on Tuesday, Jan. 21. For Jessilyn Dunn, PhD, assistant professor in the Departments of…
Durham medtech startup Deep Blue receives FDA clearance for hernia mesh product
Medtech startup Deep Blue Medical Advances can now begin selling a novel hernia mesh product with enhanced anchoring strength following receipt of FDA device (501 K) clearance, which the company announced it had received Tuesday. The T-Line Hernia…
Researchers created a test to determine which masks are the least effective
Schools are reopening, amusement parks are welcoming back visitors, and outdoor dining is the new way to eat out. But despite the signs that life is returning back to normal, the coronavirus pandemic has gone…
NC Biotech Center invested nearly $2M in state’s life science sector
The North Carolina Biotechnology Center awarded 34 grants and loans totaling nearly $2 million to universities, biosciences companies and other entities in the fourth quarter of its last fiscal year. The awards, made in April, May…
New Duke vaccine ‘works beautifully’ against breast cancer
New research out of Duke University could help the thousands of Americans stricken with breast cancer. According to new research conducted at the Duke Cancer Institute, a vaccine developed at the university for breast cancer…
Baebies Awarded $3M Grant for Pediatric Coagulation Testing
Baebies was recently awarded a Phase IIB SBIR grant from the National Institutes of Health (NIH) for a project to develop a coagulation test panel utilizing very small volumes of blood with a rapid turn-around time. Newborns…
Uplizna launch is a ‘testament’ to NC’s prowess in drug R&D
When singer songwriter Joni Mitchell wrote “…you don’t know what you’ve got ‘til it’s gone,” she didn’t know Thomas F. Tedder, Ph.D. Tedder, the Alter Geller Professor for Research in Immunology at Duke University Medical…
Evecxia Completes Series A Financing
Evecxia, Inc., a biopharmaceutical company focused on the treatment of neuropsychiatric diseases, today announced it has completed its Series A financing, raising $6.5m. This financing will fund the early development of EVX-101, the Company’s lead…
5 NC startups advance in LaunchBio’s national pitch event
LaunchBio is hosting The Big Pitch, a virtual quick pitch competition for the most promising startups in the U.S. CasTag Biosciences, Immvention Therapeutix, PhosphoGam, Praetego and TreeCo have been selected by the community to represent Durham,…